Immune profiling and monitoring
4 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
Lyon-based translational research institute specializing in preclinical validation of vaccines, antibiotics, and immunotherapies against infectious diseases.
“INCENTIVE and ImmunoSep both involve immune profiling techniques, suggesting growing capability in immunological readouts for clinical translation.”
FR8 projects - TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE
Indian translational research institute specializing in influenza vaccine development, immune profiling, and clinical validation for EU infectious disease consortia.
“INCENTIVE and INDIGO involve immune profiling, immune monitoring, and human challenge studies to evaluate vaccine responsiveness.”
PrimaryIN4 projects - STICHTING CENTRE FOR HUMAN DRUG RESEARCH
Independent Dutch clinical pharmacology center specializing in controlled human infection models, early-phase drug trials, and quantitative pharmacology for vaccines and pain therapeutics.
“INCENTIVE involves immune profiling, immune monitoring, and assessing responsiveness in vulnerable populations for influenza vaccines.”
SMENL4 projects - EUROVACC FOUNDATION
Swiss vaccine development foundation specializing in immune monitoring, clinical trial design, and translational research for HIV, influenza, and emerging infections.
“Immune monitoring appears in both EHVA (immunology platforms) and INCENTIVE (immune profiling, responsiveness assessment).”
PrimaryCH3 projects